Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Cash from Investing Activities of -$4.8 million in Q1 2026, up 71.65% quarter-over-quarter from -$16.8 million in Q4 2025, and up 39.43% on a YoY basis from -$3.4 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 39.43% year-over-year to -$4.8 million; the TTM figure through Mar 2026 stood at -$42.6 million (up 0.96% YoY), while the FY2025 annual figure was -$45.7 million, down 22.96% from the prior year.
- Cash from Investing Activities was -$4.8 million for Q1 2026 at Ascend Wellness Holdings, up from -$16.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$622000.0 in Q1 2022 to a low of -$47.7 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$15.4 million across 5 years, with a median of -$11.1 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities soared 98.23% in 2022, then sank 813.02% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$19.7 million in 2022, then soared by 58.62% to -$8.2 million in 2023, then rose by 11.8% to -$7.2 million in 2024, then slumped by 133.08% to -$16.8 million in 2025, then soared by 71.65% to -$4.8 million in 2026.
- The last three Cash from Investing Activities figures came in at -$4.8 million (Q1 2026), -$16.8 million (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.75 Mn |
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -16.76 Mn |
| Dec 31, 2025 | -16.76 Mn |
| Sep 30, 2025 | -12.54 Mn |
| Sep 30, 2025 | -12.54 Mn |
| Jun 30, 2025 | -8.59 Mn |
| Jun 30, 2025 | -8.59 Mn |
| Mar 31, 2025 | -7.85 Mn |
| Mar 31, 2025 | -7.85 Mn |
| Dec 31, 2024 | -7.19 Mn |
| Dec 31, 2024 | -7.19 Mn |
| Sep 30, 2024 | -11.14 Mn |
| Sep 30, 2024 | -11.14 Mn |
| Jun 30, 2024 | -16.88 Mn |
| Jun 30, 2024 | -16.88 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Dec 31, 2023 | -8.15 Mn |
| Dec 31, 2023 | -8.15 Mn |